O Hospital Samaritano de São Paulo é um hospital brasileiro, inaugurado em 25 de janeiro de 1894, data de aniversário de São Paulo, cidade onde se encontra. Dispõe de mais 1,2 mil médicos e uma equipe com mais de 1,6 mil profissionais.

During the past decade, Hospital Samaritano conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Samaritano" #1 sponsor was "Arbor Pharmaceuticals, Inc." with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Global Blood Therapeutics" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Samaritano" #1 collaborator was "Hospital Israelita Albert Einstein" with 2 trials as a collaborator, "Hospital Moinhos de Vento" with 2 trials as a collaborator, "Hospital do Coracao" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "BP - A Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Samaritano" are "Atypical Hemolytic Uremic Syndrome" (1 trials), "COVID-19" (1 trials), "Cardiovascular Disease" (1 trials), "Climacteric" (1 trials) and "Deep Vein Thrombosis (DVT)" (1 trials). Many other conditions were trialed in "Hospital Samaritano" in a lesser frequency.

Most popular intervention types in "Hospital Samaritano" are "Drug" (9 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "7 day antibiotic course for VAT" (1 trials), "Azilsartan Medoxomil High-dose" (1 trials), "Azilsartan Medoxomil Low-dose" (1 trials) and "Azilsartan Medoxomil Medium-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Samaritano" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Samaritano". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Samaritano, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Samaritano, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".